Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2396-832X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study ; volume:2 ; number:1 ; day:21 ; month:2 ; year:2017 ; pages:1-10 ; date:12.2017
Translational medicine communications ; 2, Heft 1 (21.2.2017), 1-10, 12.2017
- Urheber
-
Malaguarnera, Giulia
- Beteiligte Personen und Organisationen
-
Bertino, Gaetano
Greco, Carmela
Gagliano, Caterina
Motta, Massimo
Chisari, Giuseppe
Rapisarda, Venerando
Nunnari, Giuseppe
Vecchio, Michele
Drago, Filippo
Malaguarnera, Michele
SpringerLink (Online service)
- DOI
-
10.1186/s41231-016-0010-4
- URN
-
urn:nbn:de:1111-201703151001
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Malaguarnera, Giulia
- Bertino, Gaetano
- Greco, Carmela
- Gagliano, Caterina
- Motta, Massimo
- Chisari, Giuseppe
- Rapisarda, Venerando
- Nunnari, Giuseppe
- Vecchio, Michele
- Drago, Filippo
- Malaguarnera, Michele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study
Oxidative status and the response to pegylated-interferon alpha2A plus ribavirin in chronic genotype 4 HCV hepatitis
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study
Oxidative status and the response to pegylated-interferon alpha2A plus ribavirin in chronic genotype 4 HCV hepatitis
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
Hepatitis C virus core protein substitutions affect the response to pegylated-interferon and ribavirin therapy
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study
Oxidative status and the response to pegylated-interferon alpha2A plus ribavirin in chronic genotype 4 HCV hepatitis
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin